• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • PDUFA Calendar
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Contact Us
Select Page

Pharma Forecasting Case Study – Valuing the Impact of Development Delays

Aug 25, 2025 | Case Study, Case Study Forecasting

A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new formulation and packaging for an existing product. A planned reformulation seen as necessary to preserving market share had been delayed for...

Case Study Portfolio – Prioritization aligning teams on value and risk and guiding investment

Aug 25, 2025 | Case Study, Case Study Forecasting

The Asia-Pacific R&D unit of a large, multinational pharmaceutical company needed a pipeline prioritization approach to guide regional investment and development efforts to maximize continued growth. The portfolio team required a flexible approach that...

Pharma Forecasting Case Study – Shaping R&D Strategy

Aug 25, 2025 | Case Study, Case Study Forecasting, Case Study Portfolio

The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a newly acquired product. They needed to update and validate the current forecast models to identify the most effective development strategies...

Forecasting – Applying Pharmaceutical Valuation Approach in the Foster Care Setting

Aug 25, 2025 | Case Study, Case Study Forecasting

The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding to establish a new organizational structure to better support children in the Philadelphia foster care system. The proposed structure was...

PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases

Aug 25, 2025 | Case Study, Case Study Forecasting

When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team at a large, multinational pharmaceutical company turned to Ozmosi to resolve the differences. Addressing the central questions required a...

Recent Posts

  • Uncovering New Catalyst Events in the Pharmaceutical and Biotech MarketsAugust 28, 2025
  • China Reshaping the Clinical Trial PipelineAugust 28, 2025
  • Finding the Needle in a Haystack with NLPAugust 28, 2025
  • Using Data to Optimize Clinical Trial RecruitmentAugust 28, 2025
  • Healthiest States Index of The USA 2024August 28, 2025
  • New Developments in Alzheimer’s TreatmentAugust 28, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde